These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38383492)

  • 1. Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells.
    Dou Z; Lei H; Su W; Zhang T; Chen X; Yu B; Zhen X; Si J; Sun C; Zhang H; Di C
    Cell Death Dis; 2024 Feb; 15(2):160. PubMed ID: 38383492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
    Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
    Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor activity of splice-switching oligonucleotides.
    Bauman JA; Li SD; Yang A; Huang L; Kole R
    Nucleic Acids Res; 2010 Dec; 38(22):8348-56. PubMed ID: 20719743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.
    Mercatante DR; Bortner CD; Cidlowski JA; Kole R
    J Biol Chem; 2001 May; 276(19):16411-7. PubMed ID: 11278482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of RNA splicing as a potential treatment for cancer.
    Bauman JA; Kole R
    Bioeng Bugs; 2011; 2(3):125-8. PubMed ID: 21637003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA.
    Le Sénéchal R; Keruzoré M; Quillévéré A; Loaëc N; Dinh VT; Reznichenko O; Guixens-Gallardo P; Corcos L; Teulade-Fichou MP; Granzhan A; Blondel M
    Nucleic Acids Res; 2023 Nov; 51(20):11239-11257. PubMed ID: 37811881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents.
    Mercatante DR; Mohler JL; Kole R
    J Biol Chem; 2002 Dec; 277(51):49374-82. PubMed ID: 12381725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.
    Xiao Q; Ford AL; Xu J; Yan P; Lee KY; Gonzales E; West T; Holtzman DM; Lee JM
    J Neurosci; 2012 Sep; 32(39):13587-96. PubMed ID: 23015448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA.
    Lee J; Zhou J; Zheng X; Cho S; Moon H; Loh TJ; Jo K; Shen H
    Biochem Biophys Res Commun; 2012 Apr; 420(2):467-72. PubMed ID: 22440396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.
    Mogilevsky M; Shimshon O; Kumar S; Mogilevsky A; Keshet E; Yavin E; Heyd F; Karni R
    Nucleic Acids Res; 2018 Nov; 46(21):11396-11404. PubMed ID: 30329087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.
    Palve VC; Teni TR
    Radiat Oncol; 2012 Aug; 7():135. PubMed ID: 22873792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
    Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
    Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
    Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
    BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering splicing factors with designed specificities.
    Wang Y; Cheong CG; Hall TM; Wang Z
    Nat Methods; 2009 Nov; 6(11):825-30. PubMed ID: 19801992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.
    Taylor JK; Zhang QQ; Wyatt JR; Dean NM
    Nat Biotechnol; 1999 Nov; 17(11):1097-100. PubMed ID: 10545916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of alternative splicing of Bcl-x pre-mRNA in bladder cancer cells.
    Zhu Z; Xing S; Cheng P; Zeng F; Lu G
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):213-6. PubMed ID: 16850750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.
    Dou Z; Zhao D; Chen X; Xu C; Jin X; Zhang X; Wang Y; Xie X; Li Q; Di C; Zhang H
    J Exp Clin Cancer Res; 2021 Jun; 40(1):194. PubMed ID: 34118966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors.
    Murai A; Ebara S; Sasaki S; Ohashi T; Miyazaki T; Nomura T; Araki S
    PLoS One; 2020; 15(10):e0240718. PubMed ID: 33064779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis.
    DeOcesano-Pereira C; Amaral MS; Parreira KS; Ayupe AC; Jacysyn JF; Amarante-Mendes GP; Reis EM; Verjovski-Almeida S
    Nucleic Acids Res; 2014 Jul; 42(13):8343-55. PubMed ID: 24992962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing.
    Stevens M; Oltean S
    Front Genet; 2019; 10():804. PubMed ID: 31552099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.